Does dihydropyrimidine dehydrogenase level modify plasma antioxidant capacity in colorectal cancer patients treated with fluoropyrimidines?&nbsp

MLA

Velko Minchev, et al. “Does Dihydropyrimidine Dehydrogenase Level Modify Plasma Antioxidant Capacity in Colorectal Cancer Patients Treated with Fluoropyrimidines? .” Folia Medica, vol. 63, no. 5, Oct. 2021, pp. 760–67. EBSCOhost, https://doi.org/10.3897/folmed.63.e57234.

APA

Velko Minchev, Nadya Hristova-Avakumova, Kalina Kamenova, Liliya Atanasova, Marin Angelov, Lozan Todorov, Slavina Surcheva, & Rumen Nikolov. (2021). Does dihydropyrimidine dehydrogenase level modify plasma antioxidant capacity in colorectal cancer patients treated with fluoropyrimidines? . Folia Medica, 63(5), 760–767. https://doi.org/10.3897/folmed.63.e57234

Chicago

Velko Minchev, Nadya Hristova-Avakumova, Kalina Kamenova, Liliya Atanasova, Marin Angelov, Lozan Todorov, Slavina Surcheva, and Rumen Nikolov. 2021. “Does Dihydropyrimidine Dehydrogenase Level Modify Plasma Antioxidant Capacity in Colorectal Cancer Patients Treated with Fluoropyrimidines? .” Folia Medica 63 (5): 760–67. doi:10.3897/folmed.63.e57234.